Senior insider sale
SUPERNUS PHARMACEUTICALS, INC. — senior position signals high conviction
$1.00M
18.79K shares
What this filing means
GEMAYEL GEORGES plans to sell 18.79K shares of SUPERNUS PHARMACEUTICALS, INC. valued at approximately $1.00M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/6/2026ACC: 0001950047-26-002317
Director
Since Feb 2026
18.79K
Shares to sell
$1.00M
Approx. market value
8.79K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months2
Exercise of options under a registered plan
Cash
3/6/2026
3.79KPreviously Exercised Options
Cash
3/5/2026
5KTotal acquired8.79K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/6/2026 | Exercise of options under a registered plan Cash | 3.79K | — |
3/5/2026 | Previously Exercised Options Cash | 5K | — |
| Total | 8.79K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
10K
Market value
$537.1K
3/5/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
8.79K
Market value
$465.8K
3/6/2026
Total
Units
18.79K
Value
$1.00M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/5/2026 | 10K | $537.1K | — | Completed |
| Planned — Approximate Date | ||||
3/6/2026 | 8.79K | $465.8K | NASDAQ | Planned |
| Total | 18.79K | $1.00M | ||